Biocodex Acquires Majority Stake in Hilma

biote Corp Acquires Asteria Health

January 17, 2024

Healthcare Services

biote Corp. (NASDAQ: BTMD) announced a definitive agreement to acquire F.H. Investments, Inc., doing business as Asteria Health, a privately held 503B manufacturer of compounded bioidentical hormones. The deal is intended to strengthen biote’s control over its supply chain through vertical integration of hormone product manufacturing and expand biote’s capabilities in 503B manufacturing and product development.

STADA Acquires Biopharma's Pharmaceutical Prescription and Consumer Health Business

December 12, 2019

Pharmaceuticals

The STADA Group agreed to acquire the pharmaceutical prescription and consumer health business of Ukrainian producer Biopharma, including GMP-certified production facilities in Bila Tserkva. The deal integrates Biopharma's pharma operations into STADA's European organization, expands STADA's local production footprint in Ukraine and is subject to Ukrainian merger control; Biopharma's shareholders will retain the company's plasma business.

Montagu Acquires Majority Stake in HTL Biotechnology

February 28, 2022

Pharmaceuticals

Montagu, a leading private equity firm, has acquired a majority stake in HTL (HTL Biotechnology) from Bridgepoint, with minority shareholders Naxicap and Téthys Invest retaining their holdings. Montagu will support HTL's international expansion, R&D and premium product positioning and has appointed Paul Navarre as Chairman to help drive the company's next growth phase.

ORIX Corporation USA Acquires Majority Stake in Hilco Global

September 2, 2025

Financial Services

ORIX Corporation USA (ORIX USA) completed its acquisition of a majority equity ownership stake in Hilco Global, with Hilco Global operating as a subsidiary of ORIX USA. The deal combines ORIX USA’s middle-market private credit capabilities with Hilco Global’s valuation, advisory, and capital solutions platform, while Hilco Global’s executive team retains a minority equity stake.

Groupe Berkem Acquires i.Bioceuticals from International Nutrition Company (INC)

February 16, 2023

Food & Beverage

Groupe Berkem has acquired i.Bioceuticals, the exclusive North American distributor of OPC and pine bark extracts from Dutch supplier International Nutrition Company (INC). The cash transaction transfers i.Bioceuticals' Massachusetts-based team to Groupe Berkem as the Group expands its bio-based health, beauty and nutraceutical offering and strengthens its footprint in North America.

Miura Partners Acquires HTBA (HealthTech BioActives)

November 5, 2024

Biotechnology

Miura Partners has signed an agreement to acquire HTBA (HealthTech BioActives), a Barcelona-headquartered producer of flavonoids and active vitamin B12 used across pharmaceutical, nutraceutical, food & beverage and animal nutrition markets. Miura will pursue organic and inorganic initiatives to consolidate HTBA as a leading platform for natural ingredients; the deal is the third investment from Miura Fund IV and is pending approval from the Spanish regulator.